Aktuelle Optionen zur Behandlung der Riesenzellarteriitis

Translated title of the contribution: Actual Treatment Options for Giant Cell Arteritis

Frank Moosig*, Marc Schmalzing, Peer Malte Aries, Jörg C. Henes, Peter Lamprecht, Jürgen Rech, Torsten Witte

*Corresponding author for this work


To prevent serious complications such as permanent loss of vision and structural vascular damage, treatment must be initiated quickly in patients with giant-cell arteritis (GCA). So far, usually long-term corticosteroids in cumulative high dosages have been the standard therapy option. However, steroids are often insufficient to achieve adequate disease control and are associated with serious adverse events. Therefore, steroid-sparing therapy options are the focus of interest.

Translated title of the contributionActual Treatment Options for Giant Cell Arteritis
Original languageGerman
JournalDeutsche Medizinische Wochenschrift
Issue number9
Pages (from-to)595-600
Number of pages6
Publication statusPublished - 2019

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)


Dive into the research topics of 'Actual Treatment Options for Giant Cell Arteritis'. Together they form a unique fingerprint.

Cite this